Organization
Hospital de Cancer de Barretos, Barretos, Brazil
1 abstract
Abstract
Overall survival results for trifluridine/tipiracil plus bevacizumab vs capecitabine plus bevacizumab: Results from the phase 3 SOLSTICE study.Org: Hôpital Saint-Antoine, Paris, France, U.O. Oncologia Medica 2 Universitaria, Pisa, Italy, Lviv Cancer Center, Lviv, Ukraine, Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncological), Saint-Petersburg, Russian Federation, Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain,